United States

Back to map

Showing 231-240 of 353 grants

Title Institution Researcher Program Duration Total Award Amount
A pilot study assessing the safety of using a monoclonal antibody against CD40 ligand to achieve a calcineurin inhibitor-free immunosuppression regimen in patients with type 1 diabetes mellitus (T1D) and problematic hypoglycemia undergoing islet cell transplantation The University of Chicago Piotr Witkowski Cures 01-February-2025 to 31-January-2027 $1.500.000,00
Safety and efficacy assessment of Tegoprubart and calcineurin inhibitors- free immunosuppression therapy for pancreatic islet transplantation in patients with t1DM and chronic kidney disease. The University of Chicago Piotr Witkowski Cures 01-September-2025 to 31-August-2029 $8.500.000,00
Engineered Nanoparticles for Beta Cell-Targeted Therapeutics The University of Chicago Raghavendra Mirmira Cures 01-April-2023 to 31-August-2026 $897.822,00
Expanding the Therapeutic and Targeting Capacity of Lipid Nanoparticles for Beta-Cell Protection The University of Chicago Raghavendra Mirmira Cures 01-September-2026 to 31-August-2028 $471.201,00
Role of β-cell Golgi dysfunction in Type 1 diabetes pathogenesis The University of Iowa Samuel Stephens Cures 01-June-2024 to 31-May-2027 $750.000,00
The Development of 3-β-hydroxybutyrate binding protein based electrochemical micro-sensor and its application for CKM system The University of North Carolina at Chapel Hill Koji Sode Improving Lives 01-October-2022 to 30-September-2026 $799.999,96
Engineering B Cell–Targeted Microparticles to Induce Regulatory Immunity in Type 1 Diabetes The University of North Carolina at Chapel Hill Kristy Ainslie Cures 01-April-2026 to 31-March-2027 $200.000,00
Structure-switching Proteins for Continuous In Vivo C-peptide Monitoring The University of North Carolina at Chapel Hill Netz Arroyo Cures 01-October-2026 to 30-September-2029 $892.203,85
Relationships Between Executive Function Challenges and Diabetes Technology Use Among Adults with Type 1 Diabetes The University of North Carolina at Chapel Hill Rebecca Vitale Improving Lives 01-July-2026 to 30-June-2027 $49.999,80
GABP regulation of human beta cell proliferation The University of Texas Health Science Center at Houston Richard Cox Cures 01-September-2024 to 31-August-2027 $200.000,00